1987
DOI: 10.1016/s0020-1693(00)87896-2
|View full text |Cite
|
Sign up to set email alerts
|

A convenient preparation of the amminetrichloroplatinate(II) anion

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
29
0

Year Published

1987
1987
2014
2014

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 38 publications
(29 citation statements)
references
References 3 publications
0
29
0
Order By: Relevance
“…[17] [(η 5 -Cp*)Ir(dppz)(H-Gly-Met-OH- [16] and [(η 5 -Cp*)Ir(dppz)(H-Gly-Gly-Met-OH-κS)](CF 3 SO 3 ) 2 were prepared from 1 and the relevant peptide in a manner previously described for the latter complex. [14] (Et 4 N) [ [36] [(η 5 -Cp*)Ir(dppz)(H-Gly-Gly-Phe-Met-OH-κS)](CF 3 SO 3 ) 2 (3): The ligand dppz (56.5 mg, 0.2 mmol) was added to 1 (159.8 mg, 0.2 mmol) in CH 3 OH/CH 2 Cl 2 (10 mL) and the resulting solution stirred at reflux for 2 h. After addition of H-Gly-Gly-Phe-Met-OH (82.1 mg, 0.2 mmol) in CF 3 COOH (1.5 mL) and stirring at 50°C for 18 h, the volume was reduced to 3 mL. The product was precipitated by addition of diethyl ether, washed and dried in vacuo.…”
Section: Circular Dichroism Dna Binding Studies For 7-10mentioning
confidence: 99%
“…[17] [(η 5 -Cp*)Ir(dppz)(H-Gly-Met-OH- [16] and [(η 5 -Cp*)Ir(dppz)(H-Gly-Gly-Met-OH-κS)](CF 3 SO 3 ) 2 were prepared from 1 and the relevant peptide in a manner previously described for the latter complex. [14] (Et 4 N) [ [36] [(η 5 -Cp*)Ir(dppz)(H-Gly-Gly-Phe-Met-OH-κS)](CF 3 SO 3 ) 2 (3): The ligand dppz (56.5 mg, 0.2 mmol) was added to 1 (159.8 mg, 0.2 mmol) in CH 3 OH/CH 2 Cl 2 (10 mL) and the resulting solution stirred at reflux for 2 h. After addition of H-Gly-Gly-Phe-Met-OH (82.1 mg, 0.2 mmol) in CF 3 COOH (1.5 mL) and stirring at 50°C for 18 h, the volume was reduced to 3 mL. The product was precipitated by addition of diethyl ether, washed and dried in vacuo.…”
Section: Circular Dichroism Dna Binding Studies For 7-10mentioning
confidence: 99%
“…In addition to cisplatin, five other platinum complexes were examined. Two complexes with bidentate chelating ligands were chosen, [Pt-(dach)Cl 2 ], which forms the same lesions as those of oxaliplatin (23), and [Pt(en)I 2 ], a complex frequently used to model cisplatin activity (12 (27,28).…”
Section: Cis-ddp Cis-diamminedichloroplatinum(ii) (Cisplatin)mentioning
confidence: 99%
“…This work significantly extends the structural information available on platinum-DNA adducts and offers insights into the differences and common features between a variety of platinated DNA structures. (19,20). Crystallization reagents were obtained from Aldrich, Fluka, and Sigma.…”
Section: Cis-diamminedichloroplatinum(ii) Cisplatinmentioning
confidence: 99%